Introduction
============

Oxidative stress is an imbalance between oxidative and antioxidative processes *in vivo* and is involved in the pathogenesis of numerous diseases. Vascular disease is an inflammatory process, and oxidative stress has been implicated in vascular pathology ([@b1-mmr-16-03-3242],[@b2-mmr-16-03-3242]). A previous study demonstrated that treatment with fucoidan, which is an aggregate name for algal fucose-enriched sulfated polysaccharides extracted from the extracellular matrix of seaweeds, may increase oxidative stress production by activating endothelial nitric oxide synthase and promoting Akt phosphorylation in myocardial disease and stroke ([@b3-mmr-16-03-3242]). A recent study suggested that oxidative stress may be involved in high-fat diet-induced aortic remodeling, which may be exacerbated by Zn^2+^ deficiency, as the antioxidative molecule resveratrol was demonstrated to prevent high-fat diet-induced vascular inflammation, oxidative stress and pathological remodeling ([@b4-mmr-16-03-3242]). Therefore, investigating the implications of oxidative stress in the pathogenesis of vascular diseases and exploring the underlying molecular mechanisms are imperative for the development of effective preventive and therapeutic strategies aimed at patients with vascular diseases.

Signaling pathways related to oxidative stress are associated with endothelial cells that line the inner walls of blood vessels, which are continuously exposed to various stresses owing to the mechanical force exerted by blood flow and pressure, and are sensitive to oxidative damage ([@b5-mmr-16-03-3242],[@b6-mmr-16-03-3242]). A recent study demonstrated that the natural antioxidant allicin protected human umbilical vein endothelial cells (HUVECs) from oxidized low-density lipoprotein-induced injury by preventing apoptosis through the inhibition of caspase-3 and nicotinamide-adenine dinucleotide phosphate oxidase-mediated proapoptotic signaling ([@b7-mmr-16-03-3242]). Another recent study reported that resveratrol (polyphenolic compounds) treatment ameliorated high glucose-induced HUVEC injury through the activation of 5′ adenosine monophosphate-activated protein kinase α, leading to an increase in reductive reactions and a corresponding decrease in oxidative stress ([@b8-mmr-16-03-3242]). These studies suggested that oxidative stress may serve crucial roles during the development of vascular endothelial cell injury. Therefore, the present study aimed to investigate the effects of oxidative stress in HUVECs *in vitro*.

MicroRNAs (miRNAs) are small (\~22 nucleotides long) non-coding RNA molecules, which modulate the stability and the translational efficiency of target mRNA transcripts ([@b9-mmr-16-03-3242]). miRNAs are involved in the post-transcriptional regulation of gene expression and are implicated in numerous biological processes, including proliferation, differentiation, senescence and death ([@b10-mmr-16-03-3242]). Previous studies have suggested that miRNAs may be involved in the regulation of oxidative stress during vascular disease pathogenesis, serving important roles in oxidative stress-induced endothelial dysfunction and mitochondrial metabolism dysregulation ([@b1-mmr-16-03-3242],[@b11-mmr-16-03-3242]). Several miRNAs have been implicated in endothelial development, including miRNA (miR)-20a, miR-23b-3p, miR-150, miR-195 and miR-200b ([@b11-mmr-16-03-3242],[@b12-mmr-16-03-3242]). Previous studies have also revealed crucial roles for miRNAs in endothelial physiology and pathology, thus suggesting that miRNAs may have potential as novel therapeutic targets for the treatment of patients with vascular diseases ([@b13-mmr-16-03-3242],[@b14-mmr-16-03-3242]).

miR-4463 has garnered attention as a prognostic and diagnostic biomarker in patients with polycystic ovary syndrome ([@b15-mmr-16-03-3242]). In addition, our previous studies have demonstrated the aberrant expression of miR-4463 in vascular diseases, including arteriosclerosis obliterans ([@b16-mmr-16-03-3242]) and carotid artery stenosis ([@b17-mmr-16-03-3242]), which suggested that miR-4463 may also have potential as a biomarker for the early diagnosis of vascular diseases. However, the roles of miR-4463 in the regulation of oxidative stress in endothelial cells, and the molecular mechanisms underlying its actions, have yet to be elucidated. Therefore, the present study aimed to investigate the putative relationship between miR-4463 and oxidative stress, and explore the molecular mechanisms that may be involved in HUVECs.

Materials and methods
=====================

### Cell culture and oxidative stress model

The HUVEC cell line was purchased from ScienCell Research Laboratories, Inc. (Carlsbad, CA, USA) and cultured in low-glucose Dulbecco\'s modified Eagle\'s medium (DMEM; Hyclone, GE Healthcare Life Sciences, Logan, UT, USA), supplemented with 10% heat-inactivated fetal bovine serum (FBS; Gibco, Thermo Fisher Scientific, Inc., Waltham, MA, USA) and maintained in a humidified 5% CO~2~ atmosphere. Cells between passages 4 and 6, in the logarithmic phase of growth, were used in the subsequent experiments. The morphology of the cells was observed using a phase-contrast microscope (cellSens standard software version 1.6, DP72; Olympus Corporation, Tokyo, Japan).

Hydrogen peroxide (H~2~O~2~) is commonly used in models of oxidative stress-induced apoptosis ([@b18-mmr-16-03-3242]). In the present study, HUVECs were treated with various concentrations of H~2~O~2~ (200, 500, 700 and 1,000 µmol/l; [Table I](#tI-mmr-16-03-3242){ref-type="table"}) using 0.3% H~2~O~2~ stock solution, or 0 µl H~2~O~2~ (low-gluocse DMEM alone containing 10% FBS) for 16 h to induce oxidative stress, as previously described ([@b19-mmr-16-03-3242]--[@b21-mmr-16-03-3242]).

### Transfection

The intracellular level of miR-4463 was upregulated or downregulated by the transfection of miRNA mimics and inhibitor respectively, according to the manufacturer\'s protocol (Guangzhou RiboBio Co., Ltd., Guangzhou, China). The miRNA mimics synthesized by the chemical method induces a high level of expression of mature miRNA in the cell, and it enhances the regulation of endogenous miRNA and gains certain functions in cells. miRNA inhibitors inhibit the effects of mature miRNA, and weaken the role of endogenous gene regulation and cell function. When the cell density reached 50--70%, the transfection efficiency was optimal ([Table II](#tII-mmr-16-03-3242){ref-type="table"}). Transfection was performed using 100 µmol/l miR-4463 mimic or inhibitor for 15 min at room temperature, and the efficiency of transfection was determined by RT-qPCR. Finally, 100 nmol/l NC, miR-4463 mimics and miR-4463 inhibitor was chosen for the next step after 3 days transfection. NC, miR-4463 mimics and miR-4463 inhibitor sequences are listed on the Guangzhou RiboBio Co., Ltd. Website: <http://ribobio.bioon.com.cn>.

### RNA exaction and reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

Following treatment with H~2~O~2~, total RNA was extracted from HUVECs (2--3×10^5^ cells) using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.). Total RNA (500 ng) was reverse transcribed into cDNA using an miScript II RT kit (catalog no. 218160 and 21816; Qiagen GmbH, Hilden, Germany), according to manufacturer\'s protocol. The specific reaction components of reverse-transcription are mentioned in [Table III](#tIII-mmr-16-03-3242){ref-type="table"}. The mix was incubated for 60 min at 37°C, incubated for 5 min at 95°C and stored at −20°C. Acquired cDNA was used for RT-qPCR according to the manufacturer\'s protocol using the miScript SYBR-Green PCR kit (catalog no. 208054; Qiagen GmbH). Mature has-miR-4463 primer (catalog no. MIMAT0018987) and U6 primer (catalog no. MS00044996) were purchased from Qiagen GmbH. The specific reaction components of RT-qPCR are mentioned in [Table IV](#tIV-mmr-16-03-3242){ref-type="table"}, and the cycling conditions are mentioned in [Table V](#tV-mmr-16-03-3242){ref-type="table"}. qPCR was performed using the StepOnePlus version 2.2.3 real-time PCR system (Applied Biosystems; Thermo Fisher Scientific, Inc.). Relative expression levels were quantified using the 2^−ΔΔCq^ method ([@b22-mmr-16-03-3242]) and normalized to the expression of U6; Ct values \>35 were excluded. Experiments were performed in triplicate.

### Apoptosis assay

Apoptosis and necrosis were assessed using the fluorescein isothiocyanate (FITC) Annexin V and propidium iodide (PI) detection kit (BD Pharmingen; BD Biosciences, Franklin Lakes, NJ, USA), according to the manufacturer\'s protocol. Following treatment with H~2~O~2~, HUVECs (5×10^5^ cells) were washed with 10X Annexin V binding buffer, and stained for 10 min with 5 µl FITC Annexin V and 5 µl PI at room temperature in the dark. Stained cells were analyzed by flow cytometry using a BD FACSVerse and BD FACSuite^™^ software version 1.0.3 (BD Biosciences), and the experiment was repeated three times.

### Oxidative stress assays

Reactive oxygen species (ROS) production and lipid peroxidation were measured in order to assess oxidative stress in HUVECs, using ROS and malondialdehyde (MDA) detection kits (Beyotime Institute of Biotechnology, Haimen, China). Experiments were repeated \>3 times. To detect ROS production, H~2~O~2~-treated HUVECs (1×10^5^ cells) were incubated with the fluorescent probe 2′,7′-dichlorodihydrofluorescein diacetate (chloromethyl derivative) at 37°C for 30 min, as previously described ([@b23-mmr-16-03-3242]--[@b25-mmr-16-03-3242]). Subsequently, samples were digested by trypsin-EDTA solution (Beyotime Institute of Biotechnology), centrifuged (1,000 × g for 5 min at room temperature) and transferred to black 96-well plates. The fluorescence was measured using an excitation wavelength of 488 nm and an emission wavelength of 525 nm using a microplate reader. MDA is a natural product of lipid oxidation in organisms. The level of lipid oxidation may be measured by detecting the level of MDA, and therefore the determination of MDA is widely used as an indicator of lipid oxidation. To assess MDA contents in HUVECs (1×10^5^ cells), cells were lysed and then centrifuged (1,600 × g for 10 min at 4°C). A total of 100 µl supernatant and 200 µl MDA detection working fluid (150 µl TBA dilute solution, 50 µl TBA storage solution and 3 µl antioxidant) were mixed, heated at 100°C for 15 min and cooled to room temperature. The reaction mixture was centrifuged (1,000 × g for 10 min at room temperature), and subsequently transferred to 96-well plates and the absorbance was measured at 532 nm using a microplate reader, as previously described ([@b26-mmr-16-03-3242],[@b27-mmr-16-03-3242]).

### Cell proliferation assay

Cellular proliferation was evaluated using a Cell Counting Kit-8 (CCK-8; Beyotime Institute of Biotechnology), as previously described ([@b28-mmr-16-03-3242],[@b29-mmr-16-03-3242]). Following treatment with H~2~O~2~ for 16 h, HUVECs (1×10^4^ cells/well) were seeded in 96-well plates (5 wells/experimental group) in 100 µl serum-free DMEM (Hyclone; GE Healthcare Life Sciences) and 10 µl CCK-8 solution were added to each well and cells were incubated at 37°C for 35 min. The absorbance of each sample was measured at 450 nm using a microplate reader as previously described ([@b30-mmr-16-03-3242]). The percentage of living cells was calculated as a ratio of the optical density of treated cells over untreated control cells.

### Western blot analysis

Following treatment with H~2~O~2~, total protein was extracted from HUVECs (2×10^6^ cells) using Radioimmunoprecipitation Assay Lysis buffer (Beyotime Institute of Biotechnology) as previously described ([@b2-mmr-16-03-3242],[@b31-mmr-16-03-3242]). Equal amounts (20 µg) of protein in each sample (extracted using a bicinchoninic acid assay) were separated by 12% SDS-PAGE and transferred onto polyvinylidene difluoride membranes. Then, membranes were blocked for 2 h in 0.5% nonfat milk at room temperature, and washed three times for 5 mins with PBS containing 0.1% Tween-20. Next, membranes were incubated with the following primary antibodies at 4°C overnight: Anti-poly (adenosine diphosphate-ribose) polymerase 1 (PARP1; 1:1,000; catalog no. 9532), anti-X-linked inhibitor of apoptosis protein (XIAP; 1:1,000; catalog no. 14334), and anti-B cell lymphoma-2 (Bcl-2)-associated X protein (Bax; 1:1,000; catalog no. 14796) were purchased from Cell Signaling Technology, Inc. (Danvers, MA, USA); anti-active (cleaved)-caspase-3 (C-caspase-3; 1:500; catalog no. ab32042) was purchased from Abcam (Cambridge, UK); and anti-Bcl-2 (1:1,000; catalog no. AB112-1) and anti-GAPDH (1:2,000; catalog no. AF0006) were purchased from Beyotime Institute of Biotechnology. GAPDH served as the loading control ([@b18-mmr-16-03-3242],[@b19-mmr-16-03-3242]). Subsequently, membranes were incubated with the following horseradish peroxidase-conjugated secondary antibodies for 1 h at 37°C: Anti-rabbit immunoglobulin (Ig)G (1:2,000; catalog no. A0208) and anti-mouse IgG (1:3,000; catalog no. A0216) purchased from Beyotime Institute of Biotechnology. Protein bands were visualized by enhanced chemiluminescence detection reagent (Bio-Rad Laboratories, Inc., Hercules, CA, USA), and blots were semi-quantified by densitometric analysis using Quantity One version 4.6.2 software (Bio-Rad Laboratories, Inc.). Experiments were performed \>3 times.

### Statistical analysis

Statistical analysis was performed using SPSS software version 19.0 (IBM Corp., Armonk, NY, USA). Data are expressed as the mean ± standard deviation. The statistical significance of the differences between groups was assessed using one-way analysis of variance followed by a post hoc Dunnett\'s two-tailed test for multiple comparisons. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Alterations in HUVEC morphology and miR-4463 expression following treatment with H~2~O~2~

When examined under an inverted phase-contrast microscope, HUVECs in the untreated control group exhibited physiological morphology, characterized by spindle- or round-shaped cell architecture, cells that were adherent and formed paving stone-like cultures ([@b32-mmr-16-03-3242],[@b33-mmr-16-03-3242]). Conversely, the number of HUVECs in culture appeared to be markedly reduced following H~2~O~2~ treatment, with undefined boundaries and observable necrotic and disintegrative phenomena among the cells, which concurred with previously published data ([@b34-mmr-16-03-3242]--[@b36-mmr-16-03-3242]) ([Fig. 1](#f1-mmr-16-03-3242){ref-type="fig"}).

The expression levels of miR-4463 were assessed in HUVECs treated with various concentrations of H~2~O~2~. The results demonstrated that miR-4463 expression levels were significantly upregulated in H~2~O~2~-treated HUVECs in a dose-dependent manner compared with in untreated control cells ([Fig. 2](#f2-mmr-16-03-3242){ref-type="fig"}). miR-4463 expression appeared to be the highest following treatment with H~2~O~2~ at a concentration of 700 µmol/l. The high concentration of H~2~O~2~ (1,000 µmol/l) may promote cell death and inhibit the expression of the cells under oxidative stress.

### H~2~O~2~ induces apoptosis in HUVECs

Flow cytometric analysis revealed that treatment with H~2~O~2~ was able to induced apoptosis in HUVECs ([Fig. 3](#f3-mmr-16-03-3242){ref-type="fig"}). Annexin V-positive cells and cellular uptake of PI were evaluated in order to distinguish between living, apoptotic and necrotic cells, as previously described ([@b37-mmr-16-03-3242]). The proapoptotic effects of H~2~O~2~ treatment appeared to be concentration-dependent ([Fig. 3B](#f3-mmr-16-03-3242){ref-type="fig"}): No significant difference in the apoptotic rate was detected following treatment with 200 µmol/l H~2~O~2~; however, HUVEC apoptosis was significantly increased following treatment with 500 and 700 µmol/l H~2~O~2~ compared with control untreated cells (P\<0.05). As H~2~O~2~ at a concentration of 700 µmol/l appeared to produce the greatest increase in apoptotic rate (43%) and necrotic rate (8.25%), this concentration was selected for subsequent experiments.

### H~2~O~2~ induces oxidative stress in HUVECs

To confirm the induction of oxidative stress following H~2~O~2~ treatment in HUVECs, oxidative stress products were detected and cellular viability was evaluated, using commercially available kits. MDA is an end product of lipid oxidation that is involved in the oxidative damage of the cellular membrane; therefore, MDA contents may be measured as an indication of the degree of lipid peroxidation and the extent of membrane damage ([@b38-mmr-16-03-3242],[@b39-mmr-16-03-3242]). In HUVECs treated with 700 µmol/l H~2~O~2~, MDA levels were increased by 1.5-fold compared with the untreated control cells (P\<0.05; [Fig. 4A](#f4-mmr-16-03-3242){ref-type="fig"}); whereas no significant differences were indicated in HUVECs treated with 200 or 500 µmol/l H~2~O~2~. In addition, intracellular ROS production was significantly enhanced in H~2~O~2~-treated cells, as indicated by the 3.75-fold increase in ROS levels following treatment with 700 µmol/l H~2~O~2~ compared with the control. Treatment with 500 µmol/l H~2~O~2~ increased ROS levels by \~2-fold compared with the control, and there was no significant increase after treatment with 200 µmol/l H~2~O~2~ ([Fig. 4B](#f4-mmr-16-03-3242){ref-type="fig"}). Notably, no significant difference in cellular proliferation was detected between 200 µmol/l H~2~O~2~-treated HUVECs and control cells ([Fig. 4C](#f4-mmr-16-03-3242){ref-type="fig"}). However, cell proliferation and viability was significantly reduced following treatment with 500 or 700 µmol/l H~2~O~2~ ([Fig. 4C](#f4-mmr-16-03-3242){ref-type="fig"}). These findings suggested that treatment with H~2~O~2~ may induce oxidative stress in HUVECs and suppress their viability in a concentration-dependent manner.

### miR-4463 promotes H~2~O~2~-induced increases in oxidative stress

The apoptotic rate of HUVECs pretreated with miR-4463 mimics prior to H~2~O~2~ exposure was significantly increased compared with negative control-treated H~2~O~2~-exposed cells ([Fig. 5](#f5-mmr-16-03-3242){ref-type="fig"}), thus suggesting that miR-4463 may serve a role in promoting apoptosis following H~2~O~2~ treatment. Detecting NC-treated H~2~O~2~ as the control group eliminates any background effects of the transfection reagent. The roles of miR-4463 in H~2~O~2~-induced oxidative stress were also investigated, and the results revealed that intracellular ROS and MDA levels were significantly increased in H~2~O~2~-treated HUVECs following transfection with miR-4463 mimics; however, the miR-4463 inhibitor did not induce a significant difference. This suggested that miR-4463 overexpression enhanced H~2~O~2~-induced oxidative stress ([Fig. 6A and B](#f6-mmr-16-03-3242){ref-type="fig"}). However, the miR-4463 mimics did not have an exact effect on cell proliferation ([Fig. 6C](#f6-mmr-16-03-3242){ref-type="fig"}). These findings suggested that miR-4463 may enhance oxidative stress on HUVECs but have no apparent effect on the proliferation of HUVECs.

miR-4463 promotes proapoptotic signaling in H~2~O~2~-treated HUVECs. The protein expression levels of pro- and antiapoptotic markers, including C-caspase-3, Bax, Bcl-2, XIAP and PARP1, were detected in H~2~O~2~-treated HUVECs by western blot analysis ([Fig. 7](#f7-mmr-16-03-3242){ref-type="fig"}). The results demonstrated that following H~2~O~2~ treatment, the expression levels of the antiapoptotic proteins Bcl-2 and XIAP were downregulated, whereas the expression of the proapoptotic C-caspase3, PARP1 and Bax was enhanced. Notably, HUVECs pretreated with miR-4463 mimics prior to H~2~O~2~ exposure exhibited significantly increased C-caspase3, cleaved PARP and Bax protein expression levels, whereas the expression of Bcl-2 and XIAP was significantly suppressed. The present findings suggested that miR-4463 overexpression may increase the proapoptotic effects of H~2~O~2~ on HUVECs.

Discussion
==========

miRNAs are able to combine with complementary sequences in the 3′-untranslated region of target mRNA transcripts, and thus regulate the transcription of target genes and ultimately inhibit the translation of specific proteins ([@b9-mmr-16-03-3242]). miRNAs have been demonstrated previously to be involved in the regulation of HUVEC proliferation, migration and apoptosis ([@b12-mmr-16-03-3242]). In addition, miRNAs have been associated with processes involved in the development of oxidative stress ([@b24-mmr-16-03-3242]). However, the roles of miRNAs in the pathophysiology of vascular diseases, as well as their clinical value, have yet to be elucidated. Our previous study reported that miR-4463 has a greater change in the plasma levels of vascular patients ([@b16-mmr-16-03-3242]). Therefore, the present study hypothesized that miR-4463 may have an effect on the pathophysiological processes associated with vascular diseases.

H~2~O~2~ is one of the main ROS, which has been reported to decrease cellular proliferation and induce apoptosis, in a process involving several miRNAs ([@b28-mmr-16-03-3242]). Exposure of endothelial cells to H~2~O~2~ has been reported to cause cell dysfunction and promote apoptosis, thus inducing endothelial inflammation. For example, Yu *et al* ([@b40-mmr-16-03-3242]) previously demonstrated that miR-200c expression was upregulated following 100 µmol/l H~2~O~2~ treatment in BV-2 mouse microglial cells *in vitro*, whereas Zhang *et al* ([@b38-mmr-16-03-3242]) reported that miR-92a overexpression in HUVECs enhanced capillary tube formation under conditions of oxidative stress. The present study investigated the expression of miR-4463 in H~2~O~2~-treated HUVECs, and RT-qPCR analysis revealed that miR-4463 expression was upregulated following treatment with H~2~O~2~ in a concentration-dependent manner. Notably, in HUVECs treated with 1,000 µmol/l H~2~O~2~, miR-4463 expression was comparable to baseline levels. Yu *et al* ([@b40-mmr-16-03-3242]) also reported similar changes in miR-200c expression levels following spinal cord injury in murine BV-2 cells; however, the reason remains unclear and further studies are required to investigate whether high H~2~O~2~ concentration (1,000 µmol/l) may increase cell necrosis. Regardless of this discrepancy, the present results suggested that miR-4463 may serve a role in oxidative processes in HUVECs, and its expression may be regulated by H~2~O~2~ in a concentration-dependent manner.

Oxidative stress has been implicated in cellular apoptosis. In the present study, HUVEC apoptosis was investigated using flow cytometry following cell exposure to H~2~O~2~. The present results demonstrated that H~2~O~2~ increased the apoptotic rate in HUVECs in a concentration-dependent manner. Once generated, ROS readily react with unsaturated fatty acids and cholesterol molecules present in cell membranes, thus leading to cellular apoptosis through mitochondrial pathways involving nuclear factor-κB, p53 and stress-activated protein kinase ([@b41-mmr-16-03-3242]). In the present study, oxidative stress was investigated in HUVECs by assessing ROS production and MDA concentration; the results of which revealed that ROS and MDA levels were significantly increased following H~2~O~2~ treatment, whereas cell viability was significantly reduced, thus indicating that H~2~O~2~ was able to induced apoptosis in HUVECs, which is in accordance with previous studies ([@b27-mmr-16-03-3242],[@b37-mmr-16-03-3242]).

To investigate the roles of miR-4463 in oxidative pathways and cellular apoptosis, HUVECs were transfected with miR-4463 mimics or inhibitors prior to H~2~O~2~ exposure. The present results demonstrated that the apoptotic rate and the levels of oxidation products were significantly increased in HUVECs overexpressing miR-4463. However, miR-4463 inhibition did not produce a significant effect. These results suggested that miR-4463 upregulation may enhance H~2~O~2~-induced HUVEC apoptosis; however, further studies are required to confirm the exact roles of miR-4463 in HUVECs under oxidative stress and to determine the possible underlying molecular mechanisms that are involved.

Oxidative stress is a harmful mechanism for self-protection, therefore, excessive activation may enhance this effect. The results of the present study revealed that H~2~O~2~ treatment altered miR-4463 expression in HUVECs, and miR-4463 overexpression enhanced H~2~O~2~-induced oxidative stress. Therefore, the molecular mechanisms underlying the involvement of miR-4463 in apoptotic pathways were investigated in HUVECs, by assessing the expression levels of apoptosis-associated marker proteins. Following miR-4463 overexpression in H~2~O~2~-treated HUVECs, the proapoptotic proteins C-caspase3, PARP1 and Bax were significantly upregulated, whereas the protein expression of the anti-apoptotic effectors Bcl-2 and XIAP was significantly reduced. These findings suggested that miR-4463 may be implicated in the regulation of apoptosis-related protein expression in HUVECs treated with H~2~O~2~. However, further studies are required to fully elucidate the roles of miR-4463 and its target genes in apoptotic pathways.

In conclusion, the present results suggested that miR-4463 may be implicated in the pathogenesis of cardiovascular disease through the regulation of oxidative processes. Future studies will address the roles of specific target genes during the regulation of HUVEC oxidative stress and apoptosis, and the effects of miRNAs in the pathophysiological mechanisms involved in oxidative processes will be explored. The results of the present study suggested that miR-4463 may have potential for the development of novel strategies for the diagnosis, prognosis and treatment of cardiovascular diseases.

![Morphological alterations in HUVECs. Untreated control group (0 µmol/l), 200, 500, 700 and 1,000 µmol/l H~2~O~2~ treatment for 16 h. The morphology of the cells was observed by phase-contrast microscope, using ×200 magnification 200.](MMR-16-03-3242-g00){#f1-mmr-16-03-3242}

![miR-4463 expression levels in HUVECs following treatment with H~2~O~2~. HUVECs were treated with 200, 500, 700 and 1 000 µmol/l H~2~O~2~ for 16 h and miR-4463 expression was assessed using reverse transcription-quantitative polymerase chain reaction. Control cells were not exposed to H~2~O~2~. Data are expressed as the mean ± standard deviation (n=3). \*P\<0.05 vs. Control. H~2~O~2~, hydrogen peroxide; HUVEC, human umbilical vein endothelial cell; miR, microRNA.](MMR-16-03-3242-g01){#f2-mmr-16-03-3242}

![H~2~O~2~ induces apoptosis in HUVECs. HUVECs were treated with 200, 500 and 700 µmol/l H~2~O~2~ for 16 h. Control cells were not exposed to H~2~O~2~. (A) Cellular apoptosis was assessed using flow cytometry following staining with FITC Annexin V and propidium iodide. (B) Treatment with H~2~O~2~ significantly increased the apoptotic rate of HUVECs. Data are expressed as the mean ± standard deviation (n=3). \*P\<0.05 vs. Control. FITC, fluorescein isothiocyanate; H~2~O~2~, hydrogen peroxide; HUVEC, human umbilical vein endothelial cell.](MMR-16-03-3242-g02){#f3-mmr-16-03-3242}

![H~2~O~2~ induces oxidative stress in HUVECs. HUVECs were treated with 200, 500 and 700 µmol/l H~2~O~2~ for 16 h; Control cells were not exposed to H~2~O~2~. (A) MDA levels and (B) ROS production were assessed in HUVECs using commercially available kits. (C) A Cell Counting Kit-8 assay was used to evaluate cell viability. Data are expressed as the mean ± standard deviation (n=3). \*P\<0.05 vs. Control. H~2~O~2~, hydrogen peroxide; HUVEC, human umbilical vein endothelial cell; MDA, malondialdehyde; ROS, reactive oxygen species.](MMR-16-03-3242-g03){#f4-mmr-16-03-3242}

![miR-4463 enhances H~2~O~2~-induced HUVEC apoptosis. HUVECs were pretreated with a miR-4463 mimic, a miR-4463 inhibitor or NC miRNA, and then exposed to 700 µmol/l H~2~O~2~ for 16 h. Control cells did not receive treatment. (A) Cellular apoptosis was assessed using flow cytometry following staining with FITC Annexin V and propidium iodide. (B) miR-4463 overexpression enhanced the proapoptotic effects of H~2~O~2~. Data are expressed as the mean ± standard deviation (n=3). \*P\<0.05 vs. 700+NC group. miR, microRNA; H~2~O~2~, hydrogen peroxide; HUVEC, human umbilical vein endothelial cell; NC, negative control; FITC, fluorescein isothiocyanate.](MMR-16-03-3242-g04){#f5-mmr-16-03-3242}

![miR-4463 enhances H~2~O~2~-induced oxidative stress in HUVECs. HUVECs were pretreated with miR-4463 mimics, a miR-4463 inhibitor or a NC miRNA, and then exposed to 700 µmol/l H~2~O~2~ for 16 h; Control cells did not receive treatment. (A) ROS production and (B) MDA levels were assessed using commercially available kits. (C) A Cell Counting Kit-8 assay was used to evaluate cell viability. Data are expressed as the mean ± standard deviation (n=3). \*P\<0.05 vs. 700+NC group. H~2~O~2~, hydrogen peroxide; HUVEC, human umbilical vein endothelial cell; MDA, malondialdehyde; miR, microRNA; NC, negative control; ROS, reactive oxygen species.](MMR-16-03-3242-g05){#f6-mmr-16-03-3242}

![miR-4463 promotes proapoptotic signaling in H~2~O~2~-treated HUVECs. (A) HUVECs were pretreated with miR-4463 mimics, a miR-4463 inhibitor or a NC miRNA, and then exposed to 700 µmol/l H~2~O~2~ for 16 h; Control cells did not receive treatment. (B) Western blot analysis was used to assess the protein expression levels of the proapoptotic factors PARP1, Bax and C-caspase3, and the antiapoptotic factors XIAP and Bcl-2 (n=3). \*P\<0.05 vs. 700+NC. Bax, Bcl-2-associated X protein; Bcl-2, B-cell lymphoma-2; C, cleaved; H~2~O~2~, hydrogen peroxide; HUVEC, human umbilical vein endothelial cell; miR, microRNA; NC, negative control; PARP1, poly (adenosine diphosphate-ribose) polymerase 1; XIAP, X-linked inhibitor of apoptosis protein.](MMR-16-03-3242-g06){#f7-mmr-16-03-3242}

###### 

Various concentrations of H~2~O~2~.

  H~2~O~2~ concentration   0.3% H~2~O~2~   Low-glucose DMEM with 10% FBS
  ------------------------ --------------- -------------------------------
  0 µmol/l                 0.0 µl          500.0 µl
  200 µmol/l               11.4 µl         488.6 µl
  500 µmol/l               28.5 µl         471.5 µl
  700 µmol/l               39.9 µl         460.1 µl
  1,000 µmol/l             57.0 µl         443.0 µl

H~2~O~2~, hydrogen peroxide; DMEM, Dulbecco\'s modified Eagle\'s medium; FBS, fetal bovine serum.

###### 

Transfection reagent components.

  Final concentration             Final volume   Culture medium   1x riboFECT™ CP buffer   NC, miR-4463 mimics or miR-4463 inhibitor   riboFECT™ CP reagent
  ------------------------------- -------------- ---------------- ------------------------ ------------------------------------------- ----------------------
  100 nmol/l NC                   500 µl         464.5 µl         30 µl                    2.5 µl NC                                   3 µl
  100 nmol/l miR-4463 mimic       500 µl         464.5 µl         30 µl                    2.5 µl miR-4463 mimic                       3 µl
  100 nmol/l miR-4463 inhibitor   500 µl         464.5 µl         30 µl                    2.5 µl miR-4463 inhibitor                   3 µl

NC, negative control; miR, microRNA.

###### 

Reverse-transcription reaction components.

  Component                            Volume/reaction
  ------------------------------------ -------------------
  5X miScript HiSpec buffer            4 µl
  10x nucleics mix                     2 µl
  RNase-free water                     Variable
  miScript reverse transcriptase mix   2 µl
  Template RNA                         Variable (500 ng)
  Total volume                         20 µl

###### 

Reaction mix for miScript SYBR Green polymerase chain reaction.

  Component                       Volume/reaction (96-well)
  ------------------------------- ---------------------------
  2x QuantiTect SYBR-Green        12.5 µl
  PCR Master Mix                  
  10x miScript universal primer   2.5 µl
  10x miScript primer assay       2.5 µl
  RNase-free water                6.5 µl
  Diluted cDNA                    1.0 µl
  Total volume                    25.0 µl

###### 

Cycling conditions of miScript SYBR Green polymerase chain reaction.

  Cycling conditions                                           
  ----------------------------------------- ----------- ------ ----------------------------------------------------------------------------------
  Initial activation step 3-step cycling:   15 min      95°C   HotStarTaq^®^ DNA polymerase is activated by this heating step.
  Denaturation                              15 sec      94°C   
  Annealing                                 30 sec      55°C   
  Extension                                 30 sec      70°C   Perform fluorescence data collection.
  Cycle number                              40 cycles          Cycle number depends on the amount of template cDNA and abundance of the target.
